SEC Filing Details
Document Details
Form
Filing Date
Nov 7, 2023
Document Date
Sep 30, 2023
Form Description
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Group
Current Reports
Company
Ascendis Pharma
Issuer
Ascendis Pharma A/S